Global Non-oncology Biopharmaceuticals Market Research Report 2026(Status and Outlook)
Biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial. This report studies Non-oncology biopharmaceutical which are the drugs that are used in the treatment of various diseases rather than cancer.
The global Non-oncology Biopharmaceuticals market size was estimated at USD 353970.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Non-oncology Biopharmaceuticals market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Non-oncology Biopharmaceuticals market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Non-oncology Biopharmaceuticals market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-oncology Biopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Non-oncology Biopharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Non-oncology Biopharmaceuticals market size was estimated at USD 353970.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 8.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Non-oncology Biopharmaceuticals market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Non-oncology Biopharmaceuticals market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Non-oncology Biopharmaceuticals market.
Global Non-oncology Biopharmaceuticals Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Roche
- Sanofi
- Johnson & Johnson
- Pfizer
- Novo Nordisk
- Novartis
- Merck
- Teva
- Eli Lilly
- Bristol-Myers Squibb
- GlaxoSmithKline
- UCB Pharma
- Amgen
- AbbVie
- Takeda
- AstraZeneca
- Mylan
- LEO Pharma
- Boehringer Ingelheim
- Alexion Pharmaceuticals
- Elusys Therapeutics
- Swedish Orphan Biovitrum
- Biogen
Market Segmentation (by Type)
- Biologics
- Biosimilars
Market Segmentation (by Application)
- Immunology
- Endocrinology
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Non-oncology Biopharmaceuticals Market
Overview of the regional outlook of the Non-oncology Biopharmaceuticals Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Non-oncology Biopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Non-oncology Biopharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Non-oncology Biopharmaceuticals
1.2 Key Market Segments
1.2.1 Non-oncology Biopharmaceuticals Segment by Type
1.2.2 Non-oncology Biopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Non-oncology Biopharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Non-oncology Biopharmaceuticals Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Non-oncology Biopharmaceuticals Product Life Cycle
3.3 Global Non-oncology Biopharmaceuticals Sales by Manufacturers (2020-2025)
3.4 Global Non-oncology Biopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
3.5 Non-oncology Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Non-oncology Biopharmaceuticals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Non-oncology Biopharmaceuticals Market Competitive Situation and Trends
3.8.1 Non-oncology Biopharmaceuticals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Non-oncology Biopharmaceuticals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NON-ONCOLOGY BIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Non-oncology Biopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NON-ONCOLOGY BIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Non-oncology Biopharmaceuticals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Non-oncology Biopharmaceuticals Market
5.7 ESG Ratings of Leading Companies
6 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-oncology Biopharmaceuticals Sales Market Share by Type (2020-2025)
6.3 Global Non-oncology Biopharmaceuticals Market Size by Type (2020-2025)
6.4 Global Non-oncology Biopharmaceuticals Price by Type (2020-2025)
7 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-oncology Biopharmaceuticals Market Sales by Application (2020-2025)
7.3 Global Non-oncology Biopharmaceuticals Market Size (M USD) by Application (2020-2025)
7.4 Global Non-oncology Biopharmaceuticals Sales Growth Rate by Application (2020-2025)
8 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET SALES BY REGION
8.1 Global Non-oncology Biopharmaceuticals Sales by Region
8.1.1 Global Non-oncology Biopharmaceuticals Sales by Region
8.1.2 Global Non-oncology Biopharmaceuticals Sales Market Share by Region
8.2 Global Non-oncology Biopharmaceuticals Market Size by Region
8.2.1 Global Non-oncology Biopharmaceuticals Market Size by Region
8.2.2 Global Non-oncology Biopharmaceuticals Market Size by Region
8.3 North America
8.3.1 North America Non-oncology Biopharmaceuticals Sales by Country
8.3.2 North America Non-oncology Biopharmaceuticals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Non-oncology Biopharmaceuticals Sales by Country
8.4.2 Europe Non-oncology Biopharmaceuticals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Non-oncology Biopharmaceuticals Sales by Region
8.5.2 Asia Pacific Non-oncology Biopharmaceuticals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Non-oncology Biopharmaceuticals Sales by Country
8.6.2 South America Non-oncology Biopharmaceuticals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Non-oncology Biopharmaceuticals Sales by Region
8.7.2 Middle East and Africa Non-oncology Biopharmaceuticals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET PRODUCTION BY REGION
9.1 Global Production of Non-oncology Biopharmaceuticals by Region(2020-2025)
9.2 Global Non-oncology Biopharmaceuticals Revenue Market Share by Region (2020-2025)
9.3 Global Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Non-oncology Biopharmaceuticals Production
9.4.1 North America Non-oncology Biopharmaceuticals Production Growth Rate (2020-2025)
9.4.2 North America Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Non-oncology Biopharmaceuticals Production
9.5.1 Europe Non-oncology Biopharmaceuticals Production Growth Rate (2020-2025)
9.5.2 Europe Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Non-oncology Biopharmaceuticals Production (2020-2025)
9.6.1 Japan Non-oncology Biopharmaceuticals Production Growth Rate (2020-2025)
9.6.2 Japan Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Non-oncology Biopharmaceuticals Production (2020-2025)
9.7.1 China Non-oncology Biopharmaceuticals Production Growth Rate (2020-2025)
9.7.2 China Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Basic Information
10.1.2 Roche Non-oncology Biopharmaceuticals Product Overview
10.1.3 Roche Non-oncology Biopharmaceuticals Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Sanofi
10.2.1 Sanofi Basic Information
10.2.2 Sanofi Non-oncology Biopharmaceuticals Product Overview
10.2.3 Sanofi Non-oncology Biopharmaceuticals Product Market Performance
10.2.4 Sanofi Business Overview
10.2.5 Sanofi SWOT Analysis
10.2.6 Sanofi Recent Developments
10.3 Johnson and Johnson
10.3.1 Johnson and Johnson Basic Information
10.3.2 Johnson and Johnson Non-oncology Biopharmaceuticals Product Overview
10.3.3 Johnson and Johnson Non-oncology Biopharmaceuticals Product Market Performance
10.3.4 Johnson and Johnson Business Overview
10.3.5 Johnson and Johnson SWOT Analysis
10.3.6 Johnson and Johnson Recent Developments
10.4 Pfizer
10.4.1 Pfizer Basic Information
10.4.2 Pfizer Non-oncology Biopharmaceuticals Product Overview
10.4.3 Pfizer Non-oncology Biopharmaceuticals Product Market Performance
10.4.4 Pfizer Business Overview
10.4.5 Pfizer Recent Developments
10.5 Novo Nordisk
10.5.1 Novo Nordisk Basic Information
10.5.2 Novo Nordisk Non-oncology Biopharmaceuticals Product Overview
10.5.3 Novo Nordisk Non-oncology Biopharmaceuticals Product Market Performance
10.5.4 Novo Nordisk Business Overview
10.5.5 Novo Nordisk Recent Developments
10.6 Novartis
10.6.1 Novartis Basic Information
10.6.2 Novartis Non-oncology Biopharmaceuticals Product Overview
10.6.3 Novartis Non-oncology Biopharmaceuticals Product Market Performance
10.6.4 Novartis Business Overview
10.6.5 Novartis Recent Developments
10.7 Merck
10.7.1 Merck Basic Information
10.7.2 Merck Non-oncology Biopharmaceuticals Product Overview
10.7.3 Merck Non-oncology Biopharmaceuticals Product Market Performance
10.7.4 Merck Business Overview
10.7.5 Merck Recent Developments
10.8 Teva
10.8.1 Teva Basic Information
10.8.2 Teva Non-oncology Biopharmaceuticals Product Overview
10.8.3 Teva Non-oncology Biopharmaceuticals Product Market Performance
10.8.4 Teva Business Overview
10.8.5 Teva Recent Developments
10.9 Eli Lilly
10.9.1 Eli Lilly Basic Information
10.9.2 Eli Lilly Non-oncology Biopharmaceuticals Product Overview
10.9.3 Eli Lilly Non-oncology Biopharmaceuticals Product Market Performance
10.9.4 Eli Lilly Business Overview
10.9.5 Eli Lilly Recent Developments
10.10 Bristol-Myers Squibb
10.10.1 Bristol-Myers Squibb Basic Information
10.10.2 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product Overview
10.10.3 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product Market Performance
10.10.4 Bristol-Myers Squibb Business Overview
10.10.5 Bristol-Myers Squibb Recent Developments
10.11 GlaxoSmithKline
10.11.1 GlaxoSmithKline Basic Information
10.11.2 GlaxoSmithKline Non-oncology Biopharmaceuticals Product Overview
10.11.3 GlaxoSmithKline Non-oncology Biopharmaceuticals Product Market Performance
10.11.4 GlaxoSmithKline Business Overview
10.11.5 GlaxoSmithKline Recent Developments
10.12 UCB Pharma
10.12.1 UCB Pharma Basic Information
10.12.2 UCB Pharma Non-oncology Biopharmaceuticals Product Overview
10.12.3 UCB Pharma Non-oncology Biopharmaceuticals Product Market Performance
10.12.4 UCB Pharma Business Overview
10.12.5 UCB Pharma Recent Developments
10.13 Amgen
10.13.1 Amgen Basic Information
10.13.2 Amgen Non-oncology Biopharmaceuticals Product Overview
10.13.3 Amgen Non-oncology Biopharmaceuticals Product Market Performance
10.13.4 Amgen Business Overview
10.13.5 Amgen Recent Developments
10.14 AbbVie
10.14.1 AbbVie Basic Information
10.14.2 AbbVie Non-oncology Biopharmaceuticals Product Overview
10.14.3 AbbVie Non-oncology Biopharmaceuticals Product Market Performance
10.14.4 AbbVie Business Overview
10.14.5 AbbVie Recent Developments
10.15 Takeda
10.15.1 Takeda Basic Information
10.15.2 Takeda Non-oncology Biopharmaceuticals Product Overview
10.15.3 Takeda Non-oncology Biopharmaceuticals Product Market Performance
10.15.4 Takeda Business Overview
10.15.5 Takeda Recent Developments
10.16 AstraZeneca
10.16.1 AstraZeneca Basic Information
10.16.2 AstraZeneca Non-oncology Biopharmaceuticals Product Overview
10.16.3 AstraZeneca Non-oncology Biopharmaceuticals Product Market Performance
10.16.4 AstraZeneca Business Overview
10.16.5 AstraZeneca Recent Developments
10.17 Mylan
10.17.1 Mylan Basic Information
10.17.2 Mylan Non-oncology Biopharmaceuticals Product Overview
10.17.3 Mylan Non-oncology Biopharmaceuticals Product Market Performance
10.17.4 Mylan Business Overview
10.17.5 Mylan Recent Developments
10.18 LEO Pharma
10.18.1 LEO Pharma Basic Information
10.18.2 LEO Pharma Non-oncology Biopharmaceuticals Product Overview
10.18.3 LEO Pharma Non-oncology Biopharmaceuticals Product Market Performance
10.18.4 LEO Pharma Business Overview
10.18.5 LEO Pharma Recent Developments
10.19 Boehringer Ingelheim
10.19.1 Boehringer Ingelheim Basic Information
10.19.2 Boehringer Ingelheim Non-oncology Biopharmaceuticals Product Overview
10.19.3 Boehringer Ingelheim Non-oncology Biopharmaceuticals Product Market Performance
10.19.4 Boehringer Ingelheim Business Overview
10.19.5 Boehringer Ingelheim Recent Developments
10.20 Alexion Pharmaceuticals
10.20.1 Alexion Pharmaceuticals Basic Information
10.20.2 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product Overview
10.20.3 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product Market Performance
10.20.4 Alexion Pharmaceuticals Business Overview
10.20.5 Alexion Pharmaceuticals Recent Developments
10.21 Elusys Therapeutics
10.21.1 Elusys Therapeutics Basic Information
10.21.2 Elusys Therapeutics Non-oncology Biopharmaceuticals Product Overview
10.21.3 Elusys Therapeutics Non-oncology Biopharmaceuticals Product Market Performance
10.21.4 Elusys Therapeutics Business Overview
10.21.5 Elusys Therapeutics Recent Developments
10.22 Swedish Orphan Biovitrum
10.22.1 Swedish Orphan Biovitrum Basic Information
10.22.2 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product Overview
10.22.3 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product Market Performance
10.22.4 Swedish Orphan Biovitrum Business Overview
10.22.5 Swedish Orphan Biovitrum Recent Developments
10.23 Biogen
10.23.1 Biogen Basic Information
10.23.2 Biogen Non-oncology Biopharmaceuticals Product Overview
10.23.3 Biogen Non-oncology Biopharmaceuticals Product Market Performance
10.23.4 Biogen Business Overview
10.23.5 Biogen Recent Developments
11 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET FORECAST BY REGION
11.1 Global Non-oncology Biopharmaceuticals Market Size Forecast
11.2 Global Non-oncology Biopharmaceuticals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Non-oncology Biopharmaceuticals Market Size Forecast by Country
11.2.3 Asia Pacific Non-oncology Biopharmaceuticals Market Size Forecast by Region
11.2.4 South America Non-oncology Biopharmaceuticals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Non-oncology Biopharmaceuticals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Non-oncology Biopharmaceuticals Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Non-oncology Biopharmaceuticals by Type (2026-2035)
12.1.2 Global Non-oncology Biopharmaceuticals Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Non-oncology Biopharmaceuticals by Type (2026-2035)
12.2 Global Non-oncology Biopharmaceuticals Market Forecast by Application (2026-2035)
12.2.1 Global Non-oncology Biopharmaceuticals Sales (K MT) Forecast by Application
12.2.2 Global Non-oncology Biopharmaceuticals Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Non-oncology Biopharmaceuticals
1.2 Key Market Segments
1.2.1 Non-oncology Biopharmaceuticals Segment by Type
1.2.2 Non-oncology Biopharmaceuticals Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Non-oncology Biopharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Non-oncology Biopharmaceuticals Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Non-oncology Biopharmaceuticals Product Life Cycle
3.3 Global Non-oncology Biopharmaceuticals Sales by Manufacturers (2020-2025)
3.4 Global Non-oncology Biopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
3.5 Non-oncology Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Non-oncology Biopharmaceuticals Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Non-oncology Biopharmaceuticals Market Competitive Situation and Trends
3.8.1 Non-oncology Biopharmaceuticals Market Concentration Rate
3.8.2 Global 5 and 10 Largest Non-oncology Biopharmaceuticals Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NON-ONCOLOGY BIOPHARMACEUTICALS INDUSTRY CHAIN ANALYSIS
4.1 Non-oncology Biopharmaceuticals Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NON-ONCOLOGY BIOPHARMACEUTICALS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Non-oncology Biopharmaceuticals Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Non-oncology Biopharmaceuticals Market
5.7 ESG Ratings of Leading Companies
6 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-oncology Biopharmaceuticals Sales Market Share by Type (2020-2025)
6.3 Global Non-oncology Biopharmaceuticals Market Size by Type (2020-2025)
6.4 Global Non-oncology Biopharmaceuticals Price by Type (2020-2025)
7 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-oncology Biopharmaceuticals Market Sales by Application (2020-2025)
7.3 Global Non-oncology Biopharmaceuticals Market Size (M USD) by Application (2020-2025)
7.4 Global Non-oncology Biopharmaceuticals Sales Growth Rate by Application (2020-2025)
8 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET SALES BY REGION
8.1 Global Non-oncology Biopharmaceuticals Sales by Region
8.1.1 Global Non-oncology Biopharmaceuticals Sales by Region
8.1.2 Global Non-oncology Biopharmaceuticals Sales Market Share by Region
8.2 Global Non-oncology Biopharmaceuticals Market Size by Region
8.2.1 Global Non-oncology Biopharmaceuticals Market Size by Region
8.2.2 Global Non-oncology Biopharmaceuticals Market Size by Region
8.3 North America
8.3.1 North America Non-oncology Biopharmaceuticals Sales by Country
8.3.2 North America Non-oncology Biopharmaceuticals Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Non-oncology Biopharmaceuticals Sales by Country
8.4.2 Europe Non-oncology Biopharmaceuticals Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Non-oncology Biopharmaceuticals Sales by Region
8.5.2 Asia Pacific Non-oncology Biopharmaceuticals Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Non-oncology Biopharmaceuticals Sales by Country
8.6.2 South America Non-oncology Biopharmaceuticals Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Non-oncology Biopharmaceuticals Sales by Region
8.7.2 Middle East and Africa Non-oncology Biopharmaceuticals Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET PRODUCTION BY REGION
9.1 Global Production of Non-oncology Biopharmaceuticals by Region(2020-2025)
9.2 Global Non-oncology Biopharmaceuticals Revenue Market Share by Region (2020-2025)
9.3 Global Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Non-oncology Biopharmaceuticals Production
9.4.1 North America Non-oncology Biopharmaceuticals Production Growth Rate (2020-2025)
9.4.2 North America Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Non-oncology Biopharmaceuticals Production
9.5.1 Europe Non-oncology Biopharmaceuticals Production Growth Rate (2020-2025)
9.5.2 Europe Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Non-oncology Biopharmaceuticals Production (2020-2025)
9.6.1 Japan Non-oncology Biopharmaceuticals Production Growth Rate (2020-2025)
9.6.2 Japan Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Non-oncology Biopharmaceuticals Production (2020-2025)
9.7.1 China Non-oncology Biopharmaceuticals Production Growth Rate (2020-2025)
9.7.2 China Non-oncology Biopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Basic Information
10.1.2 Roche Non-oncology Biopharmaceuticals Product Overview
10.1.3 Roche Non-oncology Biopharmaceuticals Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Sanofi
10.2.1 Sanofi Basic Information
10.2.2 Sanofi Non-oncology Biopharmaceuticals Product Overview
10.2.3 Sanofi Non-oncology Biopharmaceuticals Product Market Performance
10.2.4 Sanofi Business Overview
10.2.5 Sanofi SWOT Analysis
10.2.6 Sanofi Recent Developments
10.3 Johnson and Johnson
10.3.1 Johnson and Johnson Basic Information
10.3.2 Johnson and Johnson Non-oncology Biopharmaceuticals Product Overview
10.3.3 Johnson and Johnson Non-oncology Biopharmaceuticals Product Market Performance
10.3.4 Johnson and Johnson Business Overview
10.3.5 Johnson and Johnson SWOT Analysis
10.3.6 Johnson and Johnson Recent Developments
10.4 Pfizer
10.4.1 Pfizer Basic Information
10.4.2 Pfizer Non-oncology Biopharmaceuticals Product Overview
10.4.3 Pfizer Non-oncology Biopharmaceuticals Product Market Performance
10.4.4 Pfizer Business Overview
10.4.5 Pfizer Recent Developments
10.5 Novo Nordisk
10.5.1 Novo Nordisk Basic Information
10.5.2 Novo Nordisk Non-oncology Biopharmaceuticals Product Overview
10.5.3 Novo Nordisk Non-oncology Biopharmaceuticals Product Market Performance
10.5.4 Novo Nordisk Business Overview
10.5.5 Novo Nordisk Recent Developments
10.6 Novartis
10.6.1 Novartis Basic Information
10.6.2 Novartis Non-oncology Biopharmaceuticals Product Overview
10.6.3 Novartis Non-oncology Biopharmaceuticals Product Market Performance
10.6.4 Novartis Business Overview
10.6.5 Novartis Recent Developments
10.7 Merck
10.7.1 Merck Basic Information
10.7.2 Merck Non-oncology Biopharmaceuticals Product Overview
10.7.3 Merck Non-oncology Biopharmaceuticals Product Market Performance
10.7.4 Merck Business Overview
10.7.5 Merck Recent Developments
10.8 Teva
10.8.1 Teva Basic Information
10.8.2 Teva Non-oncology Biopharmaceuticals Product Overview
10.8.3 Teva Non-oncology Biopharmaceuticals Product Market Performance
10.8.4 Teva Business Overview
10.8.5 Teva Recent Developments
10.9 Eli Lilly
10.9.1 Eli Lilly Basic Information
10.9.2 Eli Lilly Non-oncology Biopharmaceuticals Product Overview
10.9.3 Eli Lilly Non-oncology Biopharmaceuticals Product Market Performance
10.9.4 Eli Lilly Business Overview
10.9.5 Eli Lilly Recent Developments
10.10 Bristol-Myers Squibb
10.10.1 Bristol-Myers Squibb Basic Information
10.10.2 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product Overview
10.10.3 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product Market Performance
10.10.4 Bristol-Myers Squibb Business Overview
10.10.5 Bristol-Myers Squibb Recent Developments
10.11 GlaxoSmithKline
10.11.1 GlaxoSmithKline Basic Information
10.11.2 GlaxoSmithKline Non-oncology Biopharmaceuticals Product Overview
10.11.3 GlaxoSmithKline Non-oncology Biopharmaceuticals Product Market Performance
10.11.4 GlaxoSmithKline Business Overview
10.11.5 GlaxoSmithKline Recent Developments
10.12 UCB Pharma
10.12.1 UCB Pharma Basic Information
10.12.2 UCB Pharma Non-oncology Biopharmaceuticals Product Overview
10.12.3 UCB Pharma Non-oncology Biopharmaceuticals Product Market Performance
10.12.4 UCB Pharma Business Overview
10.12.5 UCB Pharma Recent Developments
10.13 Amgen
10.13.1 Amgen Basic Information
10.13.2 Amgen Non-oncology Biopharmaceuticals Product Overview
10.13.3 Amgen Non-oncology Biopharmaceuticals Product Market Performance
10.13.4 Amgen Business Overview
10.13.5 Amgen Recent Developments
10.14 AbbVie
10.14.1 AbbVie Basic Information
10.14.2 AbbVie Non-oncology Biopharmaceuticals Product Overview
10.14.3 AbbVie Non-oncology Biopharmaceuticals Product Market Performance
10.14.4 AbbVie Business Overview
10.14.5 AbbVie Recent Developments
10.15 Takeda
10.15.1 Takeda Basic Information
10.15.2 Takeda Non-oncology Biopharmaceuticals Product Overview
10.15.3 Takeda Non-oncology Biopharmaceuticals Product Market Performance
10.15.4 Takeda Business Overview
10.15.5 Takeda Recent Developments
10.16 AstraZeneca
10.16.1 AstraZeneca Basic Information
10.16.2 AstraZeneca Non-oncology Biopharmaceuticals Product Overview
10.16.3 AstraZeneca Non-oncology Biopharmaceuticals Product Market Performance
10.16.4 AstraZeneca Business Overview
10.16.5 AstraZeneca Recent Developments
10.17 Mylan
10.17.1 Mylan Basic Information
10.17.2 Mylan Non-oncology Biopharmaceuticals Product Overview
10.17.3 Mylan Non-oncology Biopharmaceuticals Product Market Performance
10.17.4 Mylan Business Overview
10.17.5 Mylan Recent Developments
10.18 LEO Pharma
10.18.1 LEO Pharma Basic Information
10.18.2 LEO Pharma Non-oncology Biopharmaceuticals Product Overview
10.18.3 LEO Pharma Non-oncology Biopharmaceuticals Product Market Performance
10.18.4 LEO Pharma Business Overview
10.18.5 LEO Pharma Recent Developments
10.19 Boehringer Ingelheim
10.19.1 Boehringer Ingelheim Basic Information
10.19.2 Boehringer Ingelheim Non-oncology Biopharmaceuticals Product Overview
10.19.3 Boehringer Ingelheim Non-oncology Biopharmaceuticals Product Market Performance
10.19.4 Boehringer Ingelheim Business Overview
10.19.5 Boehringer Ingelheim Recent Developments
10.20 Alexion Pharmaceuticals
10.20.1 Alexion Pharmaceuticals Basic Information
10.20.2 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product Overview
10.20.3 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product Market Performance
10.20.4 Alexion Pharmaceuticals Business Overview
10.20.5 Alexion Pharmaceuticals Recent Developments
10.21 Elusys Therapeutics
10.21.1 Elusys Therapeutics Basic Information
10.21.2 Elusys Therapeutics Non-oncology Biopharmaceuticals Product Overview
10.21.3 Elusys Therapeutics Non-oncology Biopharmaceuticals Product Market Performance
10.21.4 Elusys Therapeutics Business Overview
10.21.5 Elusys Therapeutics Recent Developments
10.22 Swedish Orphan Biovitrum
10.22.1 Swedish Orphan Biovitrum Basic Information
10.22.2 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product Overview
10.22.3 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product Market Performance
10.22.4 Swedish Orphan Biovitrum Business Overview
10.22.5 Swedish Orphan Biovitrum Recent Developments
10.23 Biogen
10.23.1 Biogen Basic Information
10.23.2 Biogen Non-oncology Biopharmaceuticals Product Overview
10.23.3 Biogen Non-oncology Biopharmaceuticals Product Market Performance
10.23.4 Biogen Business Overview
10.23.5 Biogen Recent Developments
11 NON-ONCOLOGY BIOPHARMACEUTICALS MARKET FORECAST BY REGION
11.1 Global Non-oncology Biopharmaceuticals Market Size Forecast
11.2 Global Non-oncology Biopharmaceuticals Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Non-oncology Biopharmaceuticals Market Size Forecast by Country
11.2.3 Asia Pacific Non-oncology Biopharmaceuticals Market Size Forecast by Region
11.2.4 South America Non-oncology Biopharmaceuticals Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Non-oncology Biopharmaceuticals by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Non-oncology Biopharmaceuticals Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Non-oncology Biopharmaceuticals by Type (2026-2035)
12.1.2 Global Non-oncology Biopharmaceuticals Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Non-oncology Biopharmaceuticals by Type (2026-2035)
12.2 Global Non-oncology Biopharmaceuticals Market Forecast by Application (2026-2035)
12.2.1 Global Non-oncology Biopharmaceuticals Sales (K MT) Forecast by Application
12.2.2 Global Non-oncology Biopharmaceuticals Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Non-oncology Biopharmaceuticals Market Size by Type (M USD)
Table 4. Global Non-oncology Biopharmaceuticals Market Size by Application
Table 5. Non-oncology Biopharmaceuticals Market Size Comparison by Region (M USD)
Table 6. Global Non-oncology Biopharmaceuticals Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Non-oncology Biopharmaceuticals Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Non-oncology Biopharmaceuticals Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Non-oncology Biopharmaceuticals Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-oncology Biopharmaceuticals as of 2025)
Table 11. Global Market Non-oncology Biopharmaceuticals Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Non-oncology Biopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non-oncology Biopharmaceuticals Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Non-oncology Biopharmaceuticals Sales by Type (K MT)
Table 27. Global Non-oncology Biopharmaceuticals Market Size by Type (M USD)
Table 28. Global Non-oncology Biopharmaceuticals Sales (K MT) by Type (2020-2025)
Table 29. Global Non-oncology Biopharmaceuticals Sales Market Share by Type (2020-2025)
Table 30. Global Non-oncology Biopharmaceuticals Market Size (M USD) by Type (2020-2025)
Table 31. Global Non-oncology Biopharmaceuticals Market Share by Type (2020-2025)
Table 32. Global Non-oncology Biopharmaceuticals Price (USD/KG) by Type (2020-2025)
Table 33. Global Non-oncology Biopharmaceuticals Sales (K MT) by Application
Table 34. Global Non-oncology Biopharmaceuticals Market Size by Application
Table 35. Global Non-oncology Biopharmaceuticals Sales by Application (2020-2025) & (K MT)
Table 36. Global Non-oncology Biopharmaceuticals Sales Market Share by Application (2020-2025)
Table 37. Global Non-oncology Biopharmaceuticals Market Size by Application (2020-2025) & (M USD)
Table 38. Global Non-oncology Biopharmaceuticals Market Share by Application (2020-2025)
Table 39. Global Non-oncology Biopharmaceuticals Sales Growth Rate by Application (2020-2025)
Table 40. Global Non-oncology Biopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 41. Global Non-oncology Biopharmaceuticals Sales Market Share by Region (2020-2025)
Table 42. Global Non-oncology Biopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 43. Global Non-oncology Biopharmaceuticals Market Size by Region (2020-2025)
Table 44. North America Non-oncology Biopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 45. North America Non-oncology Biopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Non-oncology Biopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 47. Europe Non-oncology Biopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Non-oncology Biopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Non-oncology Biopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 50. South America Non-oncology Biopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 51. South America Non-oncology Biopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Non-oncology Biopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Non-oncology Biopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 54. Global Non-oncology Biopharmaceuticals Production (K MT) by Region(2020-2025)
Table 55. Global Non-oncology Biopharmaceuticals Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Non-oncology Biopharmaceuticals Revenue Market Share by Region (2020-2025)
Table 57. Global Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Roche Basic Information
Table 63. Roche Non-oncology Biopharmaceuticals Product Overview
Table 64. Roche Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Roche Business Overview
Table 66. Roche SWOT Analysis
Table 67. Roche Recent Developments
Table 68. Sanofi Basic Information
Table 69. Sanofi Non-oncology Biopharmaceuticals Product Overview
Table 70. Sanofi Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Sanofi Business Overview
Table 72. Sanofi SWOT Analysis
Table 73. Sanofi Recent Developments
Table 74. Johnson and Johnson Basic Information
Table 75. Johnson and Johnson Non-oncology Biopharmaceuticals Product Overview
Table 76. Johnson and Johnson Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Johnson and Johnson Business Overview
Table 78. Johnson and Johnson SWOT Analysis
Table 79. Johnson and Johnson Recent Developments
Table 80. Pfizer Basic Information
Table 81. Pfizer Non-oncology Biopharmaceuticals Product Overview
Table 82. Pfizer Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Pfizer Business Overview
Table 84. Pfizer Recent Developments
Table 85. Novo Nordisk Basic Information
Table 86. Novo Nordisk Non-oncology Biopharmaceuticals Product Overview
Table 87. Novo Nordisk Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Novo Nordisk Business Overview
Table 89. Novo Nordisk Recent Developments
Table 90. Novartis Basic Information
Table 91. Novartis Non-oncology Biopharmaceuticals Product Overview
Table 92. Novartis Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Novartis Business Overview
Table 94. Novartis Recent Developments
Table 95. Merck Basic Information
Table 96. Merck Non-oncology Biopharmaceuticals Product Overview
Table 97. Merck Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Merck Business Overview
Table 99. Merck Recent Developments
Table 100. Teva Basic Information
Table 101. Teva Non-oncology Biopharmaceuticals Product Overview
Table 102. Teva Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Teva Business Overview
Table 104. Teva Recent Developments
Table 105. Eli Lilly Basic Information
Table 106. Eli Lilly Non-oncology Biopharmaceuticals Product Overview
Table 107. Eli Lilly Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Eli Lilly Business Overview
Table 109. Eli Lilly Recent Developments
Table 110. Bristol-Myers Squibb Basic Information
Table 111. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product Overview
Table 112. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Bristol-Myers Squibb Business Overview
Table 114. Bristol-Myers Squibb Recent Developments
Table 115. GlaxoSmithKline Basic Information
Table 116. GlaxoSmithKline Non-oncology Biopharmaceuticals Product Overview
Table 117. GlaxoSmithKline Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. GlaxoSmithKline Business Overview
Table 119. GlaxoSmithKline Recent Developments
Table 120. UCB Pharma Basic Information
Table 121. UCB Pharma Non-oncology Biopharmaceuticals Product Overview
Table 122. UCB Pharma Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. UCB Pharma Business Overview
Table 124. UCB Pharma Recent Developments
Table 125. Amgen Basic Information
Table 126. Amgen Non-oncology Biopharmaceuticals Product Overview
Table 127. Amgen Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Amgen Business Overview
Table 129. Amgen Recent Developments
Table 130. AbbVie Basic Information
Table 131. AbbVie Non-oncology Biopharmaceuticals Product Overview
Table 132. AbbVie Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. AbbVie Business Overview
Table 134. AbbVie Recent Developments
Table 135. Takeda Basic Information
Table 136. Takeda Non-oncology Biopharmaceuticals Product Overview
Table 137. Takeda Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Takeda Business Overview
Table 139. Takeda Recent Developments
Table 140. AstraZeneca Basic Information
Table 141. AstraZeneca Non-oncology Biopharmaceuticals Product Overview
Table 142. AstraZeneca Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. AstraZeneca Business Overview
Table 144. AstraZeneca Recent Developments
Table 145. Mylan Basic Information
Table 146. Mylan Non-oncology Biopharmaceuticals Product Overview
Table 147. Mylan Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Mylan Business Overview
Table 149. Mylan Recent Developments
Table 150. LEO Pharma Basic Information
Table 151. LEO Pharma Non-oncology Biopharmaceuticals Product Overview
Table 152. LEO Pharma Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. LEO Pharma Business Overview
Table 154. LEO Pharma Recent Developments
Table 155. Boehringer Ingelheim Basic Information
Table 156. Boehringer Ingelheim Non-oncology Biopharmaceuticals Product Overview
Table 157. Boehringer Ingelheim Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Boehringer Ingelheim Business Overview
Table 159. Boehringer Ingelheim Recent Developments
Table 160. Alexion Pharmaceuticals Basic Information
Table 161. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product Overview
Table 162. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Alexion Pharmaceuticals Business Overview
Table 164. Alexion Pharmaceuticals Recent Developments
Table 165. Elusys Therapeutics Basic Information
Table 166. Elusys Therapeutics Non-oncology Biopharmaceuticals Product Overview
Table 167. Elusys Therapeutics Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. Elusys Therapeutics Business Overview
Table 169. Elusys Therapeutics Recent Developments
Table 170. Swedish Orphan Biovitrum Basic Information
Table 171. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product Overview
Table 172. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 173. Swedish Orphan Biovitrum Business Overview
Table 174. Swedish Orphan Biovitrum Recent Developments
Table 175. Biogen Basic Information
Table 176. Biogen Non-oncology Biopharmaceuticals Product Overview
Table 177. Biogen Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 178. Biogen Business Overview
Table 179. Biogen Recent Developments
Table 180. Global Non-oncology Biopharmaceuticals Sales Forecast by Region (2026-2035) & (K MT)
Table 181. Global Non-oncology Biopharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 182. North America Non-oncology Biopharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 183. North America Non-oncology Biopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 184. Europe Non-oncology Biopharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 185. Europe Non-oncology Biopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 186. Asia Pacific Non-oncology Biopharmaceuticals Sales Forecast by Region (2026-2035) & (K MT)
Table 187. Asia Pacific Non-oncology Biopharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 188. South America Non-oncology Biopharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 189. South America Non-oncology Biopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 190. Middle East and Africa Non-oncology Biopharmaceuticals Sales Forecast by Country (2026-2035) & (Units)
Table 191. Middle East and Africa Non-oncology Biopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 192. Global Non-oncology Biopharmaceuticals Sales Forecast by Type (2026-2035) & (K MT)
Table 193. Global Non-oncology Biopharmaceuticals Market Size Forecast by Type (2026-2035) & (M USD)
Table 194. Global Non-oncology Biopharmaceuticals Price Forecast by Type (2026-2035) & (USD/KG)
Table 195. Global Non-oncology Biopharmaceuticals Sales (K MT) Forecast by Application (2026-2035)
Table 196. Global Non-oncology Biopharmaceuticals Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Non-oncology Biopharmaceuticals Market Size by Type (M USD)
Table 4. Global Non-oncology Biopharmaceuticals Market Size by Application
Table 5. Non-oncology Biopharmaceuticals Market Size Comparison by Region (M USD)
Table 6. Global Non-oncology Biopharmaceuticals Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Non-oncology Biopharmaceuticals Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Non-oncology Biopharmaceuticals Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Non-oncology Biopharmaceuticals Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-oncology Biopharmaceuticals as of 2025)
Table 11. Global Market Non-oncology Biopharmaceuticals Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Non-oncology Biopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Non-oncology Biopharmaceuticals Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Non-oncology Biopharmaceuticals Sales by Type (K MT)
Table 27. Global Non-oncology Biopharmaceuticals Market Size by Type (M USD)
Table 28. Global Non-oncology Biopharmaceuticals Sales (K MT) by Type (2020-2025)
Table 29. Global Non-oncology Biopharmaceuticals Sales Market Share by Type (2020-2025)
Table 30. Global Non-oncology Biopharmaceuticals Market Size (M USD) by Type (2020-2025)
Table 31. Global Non-oncology Biopharmaceuticals Market Share by Type (2020-2025)
Table 32. Global Non-oncology Biopharmaceuticals Price (USD/KG) by Type (2020-2025)
Table 33. Global Non-oncology Biopharmaceuticals Sales (K MT) by Application
Table 34. Global Non-oncology Biopharmaceuticals Market Size by Application
Table 35. Global Non-oncology Biopharmaceuticals Sales by Application (2020-2025) & (K MT)
Table 36. Global Non-oncology Biopharmaceuticals Sales Market Share by Application (2020-2025)
Table 37. Global Non-oncology Biopharmaceuticals Market Size by Application (2020-2025) & (M USD)
Table 38. Global Non-oncology Biopharmaceuticals Market Share by Application (2020-2025)
Table 39. Global Non-oncology Biopharmaceuticals Sales Growth Rate by Application (2020-2025)
Table 40. Global Non-oncology Biopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 41. Global Non-oncology Biopharmaceuticals Sales Market Share by Region (2020-2025)
Table 42. Global Non-oncology Biopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 43. Global Non-oncology Biopharmaceuticals Market Size by Region (2020-2025)
Table 44. North America Non-oncology Biopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 45. North America Non-oncology Biopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Non-oncology Biopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 47. Europe Non-oncology Biopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Non-oncology Biopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Non-oncology Biopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 50. South America Non-oncology Biopharmaceuticals Sales by Country (2020-2025) & (K MT)
Table 51. South America Non-oncology Biopharmaceuticals Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Non-oncology Biopharmaceuticals Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Non-oncology Biopharmaceuticals Market Size by Region (2020-2025) & (M USD)
Table 54. Global Non-oncology Biopharmaceuticals Production (K MT) by Region(2020-2025)
Table 55. Global Non-oncology Biopharmaceuticals Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Non-oncology Biopharmaceuticals Revenue Market Share by Region (2020-2025)
Table 57. Global Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Non-oncology Biopharmaceuticals Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Roche Basic Information
Table 63. Roche Non-oncology Biopharmaceuticals Product Overview
Table 64. Roche Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Roche Business Overview
Table 66. Roche SWOT Analysis
Table 67. Roche Recent Developments
Table 68. Sanofi Basic Information
Table 69. Sanofi Non-oncology Biopharmaceuticals Product Overview
Table 70. Sanofi Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Sanofi Business Overview
Table 72. Sanofi SWOT Analysis
Table 73. Sanofi Recent Developments
Table 74. Johnson and Johnson Basic Information
Table 75. Johnson and Johnson Non-oncology Biopharmaceuticals Product Overview
Table 76. Johnson and Johnson Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Johnson and Johnson Business Overview
Table 78. Johnson and Johnson SWOT Analysis
Table 79. Johnson and Johnson Recent Developments
Table 80. Pfizer Basic Information
Table 81. Pfizer Non-oncology Biopharmaceuticals Product Overview
Table 82. Pfizer Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Pfizer Business Overview
Table 84. Pfizer Recent Developments
Table 85. Novo Nordisk Basic Information
Table 86. Novo Nordisk Non-oncology Biopharmaceuticals Product Overview
Table 87. Novo Nordisk Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Novo Nordisk Business Overview
Table 89. Novo Nordisk Recent Developments
Table 90. Novartis Basic Information
Table 91. Novartis Non-oncology Biopharmaceuticals Product Overview
Table 92. Novartis Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Novartis Business Overview
Table 94. Novartis Recent Developments
Table 95. Merck Basic Information
Table 96. Merck Non-oncology Biopharmaceuticals Product Overview
Table 97. Merck Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Merck Business Overview
Table 99. Merck Recent Developments
Table 100. Teva Basic Information
Table 101. Teva Non-oncology Biopharmaceuticals Product Overview
Table 102. Teva Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Teva Business Overview
Table 104. Teva Recent Developments
Table 105. Eli Lilly Basic Information
Table 106. Eli Lilly Non-oncology Biopharmaceuticals Product Overview
Table 107. Eli Lilly Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Eli Lilly Business Overview
Table 109. Eli Lilly Recent Developments
Table 110. Bristol-Myers Squibb Basic Information
Table 111. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product Overview
Table 112. Bristol-Myers Squibb Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Bristol-Myers Squibb Business Overview
Table 114. Bristol-Myers Squibb Recent Developments
Table 115. GlaxoSmithKline Basic Information
Table 116. GlaxoSmithKline Non-oncology Biopharmaceuticals Product Overview
Table 117. GlaxoSmithKline Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. GlaxoSmithKline Business Overview
Table 119. GlaxoSmithKline Recent Developments
Table 120. UCB Pharma Basic Information
Table 121. UCB Pharma Non-oncology Biopharmaceuticals Product Overview
Table 122. UCB Pharma Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. UCB Pharma Business Overview
Table 124. UCB Pharma Recent Developments
Table 125. Amgen Basic Information
Table 126. Amgen Non-oncology Biopharmaceuticals Product Overview
Table 127. Amgen Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Amgen Business Overview
Table 129. Amgen Recent Developments
Table 130. AbbVie Basic Information
Table 131. AbbVie Non-oncology Biopharmaceuticals Product Overview
Table 132. AbbVie Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. AbbVie Business Overview
Table 134. AbbVie Recent Developments
Table 135. Takeda Basic Information
Table 136. Takeda Non-oncology Biopharmaceuticals Product Overview
Table 137. Takeda Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Takeda Business Overview
Table 139. Takeda Recent Developments
Table 140. AstraZeneca Basic Information
Table 141. AstraZeneca Non-oncology Biopharmaceuticals Product Overview
Table 142. AstraZeneca Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. AstraZeneca Business Overview
Table 144. AstraZeneca Recent Developments
Table 145. Mylan Basic Information
Table 146. Mylan Non-oncology Biopharmaceuticals Product Overview
Table 147. Mylan Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Mylan Business Overview
Table 149. Mylan Recent Developments
Table 150. LEO Pharma Basic Information
Table 151. LEO Pharma Non-oncology Biopharmaceuticals Product Overview
Table 152. LEO Pharma Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. LEO Pharma Business Overview
Table 154. LEO Pharma Recent Developments
Table 155. Boehringer Ingelheim Basic Information
Table 156. Boehringer Ingelheim Non-oncology Biopharmaceuticals Product Overview
Table 157. Boehringer Ingelheim Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Boehringer Ingelheim Business Overview
Table 159. Boehringer Ingelheim Recent Developments
Table 160. Alexion Pharmaceuticals Basic Information
Table 161. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product Overview
Table 162. Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Alexion Pharmaceuticals Business Overview
Table 164. Alexion Pharmaceuticals Recent Developments
Table 165. Elusys Therapeutics Basic Information
Table 166. Elusys Therapeutics Non-oncology Biopharmaceuticals Product Overview
Table 167. Elusys Therapeutics Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 168. Elusys Therapeutics Business Overview
Table 169. Elusys Therapeutics Recent Developments
Table 170. Swedish Orphan Biovitrum Basic Information
Table 171. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product Overview
Table 172. Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 173. Swedish Orphan Biovitrum Business Overview
Table 174. Swedish Orphan Biovitrum Recent Developments
Table 175. Biogen Basic Information
Table 176. Biogen Non-oncology Biopharmaceuticals Product Overview
Table 177. Biogen Non-oncology Biopharmaceuticals Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 178. Biogen Business Overview
Table 179. Biogen Recent Developments
Table 180. Global Non-oncology Biopharmaceuticals Sales Forecast by Region (2026-2035) & (K MT)
Table 181. Global Non-oncology Biopharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 182. North America Non-oncology Biopharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 183. North America Non-oncology Biopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 184. Europe Non-oncology Biopharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 185. Europe Non-oncology Biopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 186. Asia Pacific Non-oncology Biopharmaceuticals Sales Forecast by Region (2026-2035) & (K MT)
Table 187. Asia Pacific Non-oncology Biopharmaceuticals Market Size Forecast by Region (2026-2035) & (M USD)
Table 188. South America Non-oncology Biopharmaceuticals Sales Forecast by Country (2026-2035) & (K MT)
Table 189. South America Non-oncology Biopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 190. Middle East and Africa Non-oncology Biopharmaceuticals Sales Forecast by Country (2026-2035) & (Units)
Table 191. Middle East and Africa Non-oncology Biopharmaceuticals Market Size Forecast by Country (2026-2035) & (M USD)
Table 192. Global Non-oncology Biopharmaceuticals Sales Forecast by Type (2026-2035) & (K MT)
Table 193. Global Non-oncology Biopharmaceuticals Market Size Forecast by Type (2026-2035) & (M USD)
Table 194. Global Non-oncology Biopharmaceuticals Price Forecast by Type (2026-2035) & (USD/KG)
Table 195. Global Non-oncology Biopharmaceuticals Sales (K MT) Forecast by Application (2026-2035)
Table 196. Global Non-oncology Biopharmaceuticals Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Non-oncology Biopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-oncology Biopharmaceuticals Market Size (M USD), 2025-2035
Figure 5. Global Non-oncology Biopharmaceuticals Market Size (M USD) (2020-2035)
Figure 6. Global Non-oncology Biopharmaceuticals Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non-oncology Biopharmaceuticals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Non-oncology Biopharmaceuticals Product Life Cycle
Figure 13. Non-oncology Biopharmaceuticals Sales Share by Manufacturers in 2025
Figure 14. Global Non-oncology Biopharmaceuticals Revenue Share by Manufacturers in 2025
Figure 15. Non-oncology Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Non-oncology Biopharmaceuticals Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Non-oncology Biopharmaceuticals Revenue in 2025
Figure 18. Industry Chain Map of Non-oncology Biopharmaceuticals
Figure 19. Global Non-oncology Biopharmaceuticals Market PEST Analysis
Figure 20. Global Non-oncology Biopharmaceuticals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Non-oncology Biopharmaceuticals Market Share by Type
Figure 27. Sales Market Share of Non-oncology Biopharmaceuticals by Type (2020-2025)
Figure 28. Sales Market Share of Non-oncology Biopharmaceuticals by Type in 2025
Figure 29. Market Share of Non-oncology Biopharmaceuticals by Type (2020-2025)
Figure 30. Market Share of Non-oncology Biopharmaceuticals by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Non-oncology Biopharmaceuticals Market Share by Application
Figure 33. Global Non-oncology Biopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 34. Global Non-oncology Biopharmaceuticals Sales Market Share by Application in 2025
Figure 35. Global Non-oncology Biopharmaceuticals Market Share by Application (2020-2025)
Figure 36. Global Non-oncology Biopharmaceuticals Market Share by Application in 2025
Figure 37. Global Non-oncology Biopharmaceuticals Sales Growth Rate by Application (2020-2025)
Figure 38. Global Non-oncology Biopharmaceuticals Sales Market Share by Region (2020-2025)
Figure 39. Global Non-oncology Biopharmaceuticals Market Size by Region (2020-2025)
Figure 40. North America Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Non-oncology Biopharmaceuticals Sales Market Share by Country in 2024
Figure 43. North America Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Non-oncology Biopharmaceuticals Market Size by Country in 2024
Figure 45. U.S. Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Non-oncology Biopharmaceuticals Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Non-oncology Biopharmaceuticals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Non-oncology Biopharmaceuticals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Non-oncology Biopharmaceuticals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Non-oncology Biopharmaceuticals Sales Market Share by Country in 2024
Figure 53. Europe Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Non-oncology Biopharmaceuticals Market Size by Country in 2024
Figure 55. Germany Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Non-oncology Biopharmaceuticals Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Non-oncology Biopharmaceuticals Sales Market Share by Region in 2024
Figure 67. Asia Pacific Non-oncology Biopharmaceuticals Market Size by Region in 2024
Figure 68. China Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Non-oncology Biopharmaceuticals Sales and Growth Rate (K MT)
Figure 79. South America Non-oncology Biopharmaceuticals Sales Market Share by Country in 2024
Figure 80. South America Non-oncology Biopharmaceuticals Market Size and Growth Rate (M USD)
Figure 81. South America Non-oncology Biopharmaceuticals Market Size by Country in 2024
Figure 82. Brazil Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Non-oncology Biopharmaceuticals Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Non-oncology Biopharmaceuticals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Non-oncology Biopharmaceuticals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Non-oncology Biopharmaceuticals Market Size by Region in 2024
Figure 92. Saudi Arabia Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Non-oncology Biopharmaceuticals Production Market Share by Region (2020-2025)
Figure 103. North America Non-oncology Biopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Non-oncology Biopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Non-oncology Biopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 106. China Non-oncology Biopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Non-oncology Biopharmaceuticals Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Non-oncology Biopharmaceuticals Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Non-oncology Biopharmaceuticals Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Non-oncology Biopharmaceuticals Market Share Forecast by Type (2026-2035)
Figure 111. Global Non-oncology Biopharmaceuticals Sales Forecast by Application (2026-2035)
Figure 112. Global Non-oncology Biopharmaceuticals Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Non-oncology Biopharmaceuticals
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Non-oncology Biopharmaceuticals Market Size (M USD), 2025-2035
Figure 5. Global Non-oncology Biopharmaceuticals Market Size (M USD) (2020-2035)
Figure 6. Global Non-oncology Biopharmaceuticals Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Non-oncology Biopharmaceuticals Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Non-oncology Biopharmaceuticals Product Life Cycle
Figure 13. Non-oncology Biopharmaceuticals Sales Share by Manufacturers in 2025
Figure 14. Global Non-oncology Biopharmaceuticals Revenue Share by Manufacturers in 2025
Figure 15. Non-oncology Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Non-oncology Biopharmaceuticals Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Non-oncology Biopharmaceuticals Revenue in 2025
Figure 18. Industry Chain Map of Non-oncology Biopharmaceuticals
Figure 19. Global Non-oncology Biopharmaceuticals Market PEST Analysis
Figure 20. Global Non-oncology Biopharmaceuticals Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Non-oncology Biopharmaceuticals Market Share by Type
Figure 27. Sales Market Share of Non-oncology Biopharmaceuticals by Type (2020-2025)
Figure 28. Sales Market Share of Non-oncology Biopharmaceuticals by Type in 2025
Figure 29. Market Share of Non-oncology Biopharmaceuticals by Type (2020-2025)
Figure 30. Market Share of Non-oncology Biopharmaceuticals by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Non-oncology Biopharmaceuticals Market Share by Application
Figure 33. Global Non-oncology Biopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 34. Global Non-oncology Biopharmaceuticals Sales Market Share by Application in 2025
Figure 35. Global Non-oncology Biopharmaceuticals Market Share by Application (2020-2025)
Figure 36. Global Non-oncology Biopharmaceuticals Market Share by Application in 2025
Figure 37. Global Non-oncology Biopharmaceuticals Sales Growth Rate by Application (2020-2025)
Figure 38. Global Non-oncology Biopharmaceuticals Sales Market Share by Region (2020-2025)
Figure 39. Global Non-oncology Biopharmaceuticals Market Size by Region (2020-2025)
Figure 40. North America Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Non-oncology Biopharmaceuticals Sales Market Share by Country in 2024
Figure 43. North America Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Non-oncology Biopharmaceuticals Market Size by Country in 2024
Figure 45. U.S. Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Non-oncology Biopharmaceuticals Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Non-oncology Biopharmaceuticals Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Non-oncology Biopharmaceuticals Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Non-oncology Biopharmaceuticals Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Non-oncology Biopharmaceuticals Sales Market Share by Country in 2024
Figure 53. Europe Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Non-oncology Biopharmaceuticals Market Size by Country in 2024
Figure 55. Germany Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Non-oncology Biopharmaceuticals Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Non-oncology Biopharmaceuticals Sales Market Share by Region in 2024
Figure 67. Asia Pacific Non-oncology Biopharmaceuticals Market Size by Region in 2024
Figure 68. China Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Non-oncology Biopharmaceuticals Sales and Growth Rate (K MT)
Figure 79. South America Non-oncology Biopharmaceuticals Sales Market Share by Country in 2024
Figure 80. South America Non-oncology Biopharmaceuticals Market Size and Growth Rate (M USD)
Figure 81. South America Non-oncology Biopharmaceuticals Market Size by Country in 2024
Figure 82. Brazil Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Non-oncology Biopharmaceuticals Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Non-oncology Biopharmaceuticals Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Non-oncology Biopharmaceuticals Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Non-oncology Biopharmaceuticals Market Size by Region in 2024
Figure 92. Saudi Arabia Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Non-oncology Biopharmaceuticals Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Non-oncology Biopharmaceuticals Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Non-oncology Biopharmaceuticals Production Market Share by Region (2020-2025)
Figure 103. North America Non-oncology Biopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Non-oncology Biopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Non-oncology Biopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 106. China Non-oncology Biopharmaceuticals Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Non-oncology Biopharmaceuticals Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Non-oncology Biopharmaceuticals Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Non-oncology Biopharmaceuticals Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Non-oncology Biopharmaceuticals Market Share Forecast by Type (2026-2035)
Figure 111. Global Non-oncology Biopharmaceuticals Sales Forecast by Application (2026-2035)
Figure 112. Global Non-oncology Biopharmaceuticals Market Share Forecast by Application (2026-2035)